DRREDDY.BO

Dr. Reddy's Laboratories Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,279.25

Jun 15, 2026

AI Brief

Market cap

$1.07T

52w range

—

P / E

—

EPS · FY 2026

$51.42

Volume

—

Revenue · FY 2026

$335.93B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Dr. Reddy's Laboratories Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1279.25

Change

+8.16%

Period high

$1336.95

Period low

$1182.35

Period start

$1182.752026-02-01

Through 2026-06-15

Fair value

Football field →

Weighted blend

$1,116.74

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

DRREDDY.BO

1,279+8.16%

H 1,347L 1,167MA50 1,283MA200 —Avg vol 53K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Industrials
+0.94%
Utilities
+0.89%
Consumer Defensive
+0.70%
Basic Materials
+0.56%
Consumer Cyclical
+0.37%
Energy
+0.23%
Financial Services
+0.18%
Real Estate
-0.05%
Healthcare
-0.48%
Technology
-0.99%
Communication Services
-1.29%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
-0.72%
Broadcasting
-3.65%
Electronic Gaming & Multimedia
+3.22%
Communication Equipment
-3.15%
Hardware, Equipment & Parts
-2.87%
Independent Power Producers
+2.78%
Medical - Equipment & Services
+2.51%
Internet Content & Information
-2.07%
Conglomerates
+1.88%
Trucking
-1.86%
Construction Materials
+1.80%
Furnishings, Fixtures & Appliances
+1.63%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for DRREDDY.BO.

Peers

No peer list available for DRREDDY.BO.

Total assets

$579.35B

Total debt

$77.34B

Cash & equiv

$15.37B

Operating CF

$53.84B

Free cash flow

$30.51B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$335.93B	$46.44B	$42.85B	$51.42	+12.76%